Credit: NIAID
Scientists at the University of Southampton s Centre for Cancer Immunology have gained new insight into how the immune system can be better used to find and kill cancer cells.
Working with BioInvent International, a team led by Professor Mark Cragg and Dr Jane Willoughby from the Antibody and Vaccine Group, based at the Centre, have shown that antibodies, designed to target the molecule OX40, give a more active immune response when they bind closer to the cell membrane and can be modified to attack cancer in different ways.
OX40 is a co-receptor that helps to stimulate the production of helper and killer T-cells during an immune response. One of the ways cancer avoids detection is by suppressing immune responses to stop functional tumour specific T-cells from being produced.
Credit: Stevepb/pixabay
Hundreds of cancer patients have benefitted from using computer algorithms to manage their symptoms and improve their wellbeing in a unique UK trial.
The early stage colorectal, breast or gynecological cancer patients took part in the trial of the eRAPID system, developed by the University of Leeds, which allowed them to report online symptoms from home and receive instant advice on whether to self-manage or seek medical attention.
Patients reported better symptom control and physical wellbeing in the early weeks of treatment, with the system preventing symptom deterioration in about 9% of patients after 12 weeks. Patients reported more confidence in managing their health at the end of their four-month trial period.
Vital Farms to Participate in the 2021 Annual ICR Conference
Vital Farms to Participate in the 2021 Annual ICR Conference
AUSTIN, Texas, Jan. 06, 2021 Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced pasture-raised foods nationwide, today announced that Russell Diez-Canseco, President and Chief Executive Officer, and Bo Meissner, Chief Financial Officer, will participate in a fireside chat hosted by Rupesh Parikh, Senior Research Analyst at Oppenheimer & Co., at the 2021 Annual ICR Conference.
The discussion will take place on Tuesday, January 12, 2021 at 10:30 a.m. ET, or 9:30 a.m. CT. Participants may access the live webcast under the “Events & Presentations” tab of the Vital Farms Investor Relations site: https://investors.vitalfarms.com/investor-relations. Following the discussion, a replay will be archived on the Company’s Investor Relations site for 90 days.
Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
TEMPLE CITY, Calif., Jan. 06, 2021 Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that its Chief Financial Officer Paul Kim, and Chief Commercial Officer Brandon Perthuis are scheduled to virtually participate in a presentation at the H.C. Wainwright BIOCONNECT 2021 Conference taking place January 11 to 14, 2021.
A webcast of the presentation will be available beginning at 6:00 a.m. ET on January 11, 2021 on the Investor Relations section of the Fulgent Genetics website at ir.fulgentgenetics.com, and will be available for 90 days following the conference.
Ingreso a la UNAM 2021: así te puedes registrar para presentar el examen de admisión en febrero y marzo infobae.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infobae.com Daily Mail and Mail on Sunday newspapers.